All Stories

  1. Predicting metabolic responses in genetic disorders via structural representation in machine learning
  2. Characterization of bacterial communities associated with seabed sediments in offshore and nearshore sites to improve Microbiologically Influenced Corrosion mitigation on marine infrastructures
  3. Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
  4. New findings about neuropathological outcomes in the PKU mouse throughout lifespan
  5. Biochemical Studies on Human Ornithine Aminotransferase Support a Cell-Based Enzyme Replacement Therapy in the Gyrate Atrophy of the Choroid and Retina
  6. Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules
  7. Exploring Machine Learning for Untargeted Metabolomics Using Molecular Fingerprints
  8. CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study
  9. Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody
  10. Old and new strategies in therapy and diagnosis against fungal infections
  11. A synthetic thiol molecule releasing N-acetyl-l-cysteine and cysteamine drives early up-regulation of immunoproteasome subunits in the lymph nodes of mice infected with LP-BM5 leukemia retrovirus
  12. Drug transport by red blood cells
  13. Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis
  14. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
  15. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
  16. Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications
  17. Assessment of a new UV-C light-emitting diode–based technology for air sanitization in indoor sports environments
  18. Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
  19. Sirtuin 6 Regulates the Activation of the ATP/Purinergic Axis in Endothelial Cells
  20. Clonal Spread of Hospital-Acquired NDM-1-Producing Klebsiella pneumoniae and Escherichia coli in an Italian Neonatal Surgery Unit: A Retrospective Study
  21. Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells
  22. Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs
  23. AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability
  24. Targeting SARS‐CoV ‐2 by synthetic dual‐acting thiol compounds that inhibit Spike/ ACE2 interaction and viral protein production
  25. New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
  26. Development and in vitro characterization of a humanized scFv against fungal infections
  27. Meet the Editorial Board Member
  28. Functionalized 3D scaffolds for engineering the hematopoietic niche
  29. The host micro-RNA cfa-miR-346 is induced in canine leishmaniasis
  30. Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine
  31. SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy
  32. Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment
  33. CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML
  34. Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
  35. Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in Italy
  36. External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
  37. Airborne Microorganism Inactivation by a UV-C LED and Ionizer-Based Continuous Sanitation Air (CSA) System in Train Environments
  38. Influenza Virus Down-Modulates G6PD Expression and Activity to Induce Oxidative Stress and Promote Its Replication
  39. Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms
  40. SPIO nanoparticles and magnetic erythrocytes as contrast agents for biomedical and diagnostic applications
  41. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS–FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity
  42. Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human Cells
  43. Gastrointestinal Tumors: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer
  44. Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
  45. A new humanized antibody is effective against pathogenic fungi in vitro
  46. Meet the Editorial Board Member
  47. Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
  48. Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency
  49. Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants
  50. In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
  51. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
  52. The nucleoplasmic interactions among Lamin A/C-pRB-LAP2α-E2F1 are modulated by dexamethasone
  53. Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection
  54. Human Red Blood Cells Modulate Cytokine Expression in Monocytes/Macrophages Under Anoxic Conditions
  55. Activation of NRF2 and ATF4 Signaling by the Pro-Glutathione Molecule I-152, a Co-Drug of N-Acetyl-Cysteine and Cysteamine
  56. Carriage of Carbapenem-Resistant Enterobacterales in Adult Patients Admitted to a University Hospital in Italy
  57. Transcriptomic profile of ataxia telangiectasia cells treated for 30 days with a low dose of dexamethasone
  58. Preclinical developments of enzyme-loaded red blood cells
  59. Evaluation of a kDNA-Based qPCR Assay for the Detection and Quantification of Old World Leishmania Species
  60. I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response
  61. Missense mutations in EDA and EDAR genes cause dominant syndromic tooth agenesis
  62. Redox homeostasis as a target for new antimycobacterial agents
  63. Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells
  64. Basic and applied science at the time of COVID‐19
  65. Antiviral Properties of Flavonoids and Delivery Strategies
  66. The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells
  67. Meet Our Editorial Board Member
  68. TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
  69. Redox-Modulating Agents in the Treatment of Viral Infections
  70. Differentiation of Leishmania (L.) infantum, Leishmania (L.) amazonensis and Leishmania (L.) mexicana Using Sequential qPCR Assays and High-Resolution Melt Analysis
  71. Plasmid Replicon Typing of Antibiotic-Resistant Escherichia coli From Clams and Marine Sediments
  72. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication
  73. In Ataxia-Telangiectasia, Oral Betamethasone Administration Ameliorates Lymphocytes Functionality through Modulation of the IL-7/IL-7Rα Axis Paralleling the Neurological Behavior: A Comparative Report of Two Cases
  74. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab
  75. Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes
  76. Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies
  77. Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  78. A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4
  79. Real-time PCR to differentiate among Leishmania (Viannia) subgenus, Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis: Application on Brazilian clinical samples
  80. DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia
  81. A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription
  82. Data on the differentiation among Leishmania (Viannia) spp., Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis in Brazilian clinical samples using real-time PCR
  83. Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study
  84. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
  85. Red Blood Cell Membrane Processing for Biomedical Applications
  86. Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  87. Corrigendum: GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  88. XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT
  89. Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of N-acetyl-cysteine and β-mercaptoethylamine
  90. Secosterol-B affects endoplasmic reticulum structure in endothelial cells
  91. Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38
  92. FKBP5 rs4713916: A Potential Genetic Predictor of Interindividual Different Response to Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease in a Real-Life Setting
  93. Effects in Cancer Cells of the Recombinant l-Methionine Gamma-Lyase from Brevibacterium aurantiacum. Encapsulation in Human Erythrocytes for Sustained l-Methionine Elimination
  94. Identification, Expression and Preliminary Characterization of a Recombinant Bifunctional Enzyme of Photobacterium damselae subsp. piscicida with Glutamate Decarboxylase/Transaminase Activity
  95. Glutathione increase by the n-butanoyl glutathione derivative (GSH-C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus
  96. Magnetic Manipulation of Blood Conductivity with Superparamagnetic Iron Oxide-Loaded Erythrocytes
  97. Biochemical Properties and Oxalate‐Degrading Activity of Oxalate Decarboxylase from Bacillus subtilis at Neutral pH
  98. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
  99. GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  100. The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
  101. Evaluation of PCR-based methods for the identification of enteroaggregative hemorrhagic Escherichia coli in sprouts
  102. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors
  103. Exploiting genetic polymorphisms in metabolic enzymes for rapid screening of Leishmania infantum genotypes
  104. Humanization of Antibodies using a Statistical Inference Approach
  105. Induction of ubiquitin C (UBC ) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress
  106. Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes
  107. Leishmania Infection Induces MicroRNA hsa-miR-346 in Human Cell Line-Derived Macrophages
  108. Real-time PCR applications for diagnosis of leishmaniasis
  109. A new therapy prevents intellectual disability in mouse with phenylketonuria
  110. Comparison of the Diatheva STEC FLUO with BAX System Kits for Detection of O157:H7 and Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) in Ground Beef and Bean Sprout Samples Using Different Enrichment Protocols
  111. Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone
  112. Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice
  113. Ataxia-telangiectasia
  114. Detection of Shiga toxin-producing Escherichia coli (STEC) in ground beef and bean sprouts: Evaluation of culture enrichment conditions
  115. MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
  116. Endothelial cells, endoplasmic reticulum stress and oxysterols
  117. Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells
  118. Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
  119. Engineered red blood cells as therapeutic agents
  120. Endoplasmic reticulum stress and unfolded protein response in infection by intracellular parasites
  121. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia
  122. ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T
  123. Validation and application of a quantitative real-time PCR assay to detect common wheat adulteration of durum wheat for pasta production
  124. The use of kDNA minicircle subclass relative abundance to differentiate between Leishmania (L.) infantum and Leishmania (L.) amazonensis
  125. Comparative analysis of the standard PCR-Based Replicon Typing (PBRT) with the commercial PBRT-KIT
  126. Determination of Interference DuringIn VitroPyrogen Detection: Development and Characterization of a Cell-Based Assay
  127. Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor
  128. Reengineering red blood cells for cellular therapeutics and diagnostics
  129. Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents
  130. Glutathione and its derivatives for the treatment of microbial infections.
  131. Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment
  132. Leishmania infantum Induces Mild Unfolded Protein Response in Infected Macrophages
  133. Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone
  134. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution
  135. Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents
  136. Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response
  137. Enterococcus faeciumST17 from Coastal Marine Sediment Carrying Transferable Multidrug Resistance Plasmids
  138. Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)
  139. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
  140. LP-BM5 infection and glutathione
  141. Erythrocyte-mediated delivery of recombinant enzymes
  142. Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
  143. Validation of a Reversed-Phase High Performance Liquid Chromatography Method for the Simultaneous Analysis of Cysteine and Reduced Glutathione in Mouse Organs
  144. Modulation of Stat-1 in Human Macrophages Infected with Different Species of Intracellular Pathogenic Bacteria
  145. Selection of Vaccine Candidates for Fish Pasteurellosis Using Reverse Vaccinology and an In Vitro Screening Approach
  146. Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma
  147. Retrieving embryo genetic information from spent culture medium
  148. Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants
  149. The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro
  150. Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment
  151. Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions
  152. Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells
  153. Label-free quantification of Tacrolimus in biological samples by atomic force microscopy
  154. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
  155. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
  156. Validation according to ISO/TS 12869:2012 of a molecular method for the isolation and quantification of Legionella spp. in water
  157. Selective protein detection with a dsLNA-functionalized nanopore
  158. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies
  159. Anti influenza therapy
  160. Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources
  161. CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
  162. Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
  163. A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients
  164. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice
  165. Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters
  166. Red Blood Cells as Carriers of Iron Oxide-Based Contrast Agents for Diagnostic Applications
  167. Enhancing neutral lipid content in Skeletonema marinoi through multiple phase growth in a bench photobioreactor
  168. Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: Design and characterization of the enzymatic properties
  169. Promoter-specific relevance of histone modifications induced by dexamethasone during the regulation of pro-inflammatory mediators
  170. Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
  171. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system
  172. Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy
  173. Effect of the N-butanoyl glutathione (GSH) derivative and acyclovir on HSV-1 replication and Th1 cytokine expression in human macrophages
  174. Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy
  175. Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells
  176. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study
  177. An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
  178. Approaches to erythrocyte-mediated drug delivery
  179. Detection and Characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR Green-Based Real-Time PCR and High Resolution Melt Analysis Targeting Kinetoplast Minicircle DNA
  180. Erythrocytes as Carriers for Drugs and Contrast Agents
  181. Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial
  182. Photobacteriosis: Prevention and Diagnosis
  183. Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system
  184. New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI
  185. Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation
  186. Recent advances in synthesis, characterization of hydroxyapatite/polyurethane composites and study of their biocompatible properties
  187. Yin Yang 1 Intronic Binding Sequences and Splicing Elicit Intron-Mediated Enhancement of Ubiquitin C Gene Expression
  188. Genomic DNA in human blastocoele fluid
  189. Neutral Lipid Content and Biomass Production in Skeletonema marinoi (Bacillariophyceae) Culture in Response to Nitrate Limitation
  190. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection
  191. Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis
  192. Magnetic red blood cells as new contrast agents for MRI applications
  193. Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages
  194. Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies
  195. Use of red blood cells as new strategy to avoid the rapid clearance of SPIOs nanoparticles
  196. Isolation of a novel gene from Photobacterium damselae subsp. piscicida and analysis of the recombinant antigen as promising vaccine candidate
  197. Red blood cells as carriers in magnetic particle imaging
  198. Deciphering the single-cell omic: innovative application for translational medicine
  199. CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors
  200. HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
  201. Dexamethasone Partially Rescues Ataxia Telangiectasia-mutated (ATM) Deficiency in Ataxia Telangiectasia by Promoting a Shortened Protein Variant Retaining Kinase Activity
  202. Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines
  203. Palytoxin and an Ostreopsis Toxin Extract Increase the Levels of mRNAs Encoding Inflammation-Related Proteins in Human Macrophages via p38 MAPK and NF-κB
  204. The expression and modulation of CEACAM1 and tumor cell transformation
  205. High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
  206. Microbiological Surveillance of a Bovine Raw Milk Farm Through Multiplex Real-Time PCR
  207. Unique Toxin Profile of a Mediterranean Ostreopsis cf. ovata Strain: HR LC-MSn Characterization of Ovatoxin-f, a New Palytoxin Congener
  208. Development of a multilevel approach for the evaluation of nanomaterials’ toxicity
  209. Erythrocytes as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics
  210. Erythrocytes as carriers for drugs: the transition from the laboratory to the clinic is approaching
  211. Involvement of Stat1 in the Phagocytosis ofM. avium
  212. Red Blood Cells as Magnetic Carriers for MPI Applications
  213. Corrigendum: Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  214. Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
  215. Application of the standard addition method for the absolute quantification of neutral lipids in microalgae using Nile red
  216. Binding force measurement of NF-κB–ODNs interaction: An AFM based decoy and drug testing tool
  217. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules
  218. Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs
  219. Redox Regulation of the Influenza Hemagglutinin Maturation Process: A New Cell-Mediated Strategy for Anti-Influenza Therapy
  220. Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms
  221. Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages
  222. Drug delivery by red blood cells
  223. Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer
  224. A practical and expeditious method for the preparation of the potential anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b′:7,8-b″:10,11-b‴]tetraindole (CTet)
  225. Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational status
  226. Development of an oligonucleotide microarray for the detection and monitoring of marine dinoflagellates
  227. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents
  228. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines
  229. Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients
  230. Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy
  231. The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice
  232. Electrical characterization of DNA-functionalized solid state nanopores for bio-sensing
  233. Human erythrocytes as nanoparticle carriers for magnetic particle imaging
  234. Improved cellular uptake of functionalized single-walled carbon nanotubes
  235. Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy
  236. Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  237. Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking
  238. A multiplex magnetic capture hybridisation and multiplex Real-Time PCR protocol for pathogen detection in seafood
  239. Label-free quantification of activated NF-κB in biological samples by atomic force microscopy
  240. Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24- Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)
  241. Oxidized Ultrashort Nanotubes as Carbon Scaffolds for the Construction of Cell-Penetrating NF-κB Decoy Molecules
  242. Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan
  243. Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
  244. The preventive phase I trial with the HIV-1 Tat-based vaccine
  245. A potent enhancer element in the 5′-UTR intron is crucial for transcriptional regulation of the human ubiquitin C gene
  246. Parallel Conduction of the Phase I Preventive and Therapeutic Trials Based on the Tat Vaccine Candidate
  247. A new platform for Real-Time PCR detection of Salmonella spp., Listeria monocytogenes and Escherichia coli O157 in milk
  248. Expression and characterization of the periplasmic cobalamin-binding protein ofPhotobacterium damselaesubsp.piscicida
  249. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population
  250. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity
  251. Development of a multiplex PCR assay forPhotobacterium damselaesubsp.piscicidaidentification in fish samples
  252. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis
  253. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
  254. PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
  255. SIMULTANEOUS DIRECT DETECTION OFSALMONELLASPP.,LISTERIA MONOCYTOGENESANDESCHERICHIA COLIO157 IN MILK SAMPLES BY MAGNETIC EXTRACTION AND MULTIPLEX PCR
  256. Expression, Purification, and Characterization of the Recombinant Putative Periplasmic Hemin-Binding Protein (HutB) ofPhotobacterium damselaesubsp.piscicida
  257. De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-κB/IKK basal activity
  258. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
  259. Erythrocytes as carriers of antisense PNA addressed against HIV-1gag-poltransframe domain
  260. Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria
  261. Analysis of rRNA gene content in the Mediterranean dinoflagellate Alexandrium catenella and Alexandrium taylori: implications for the quantitative real-time PCR-based monitoring methods
  262. HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection
  263. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS)
  264. GSH and analogs in antiviral therapy
  265. High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene
  266. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
  267. High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
  268. Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells
  269. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein
  270. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population
  271. Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study
  272. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
  273. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
  274. Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
  275. Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells
  276. Selective Killing ofMycobacterium avium–Infected Macrophages by Inhibition of Phosphorylated Signal Transducer and Activator of Transcription Type 1
  277. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population
  278. New Biomimetic Constructs for Improved In Vivo Circulation of Superparamagnetic Nanoparticles
  279. Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer
  280. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients
  281. Prolonged Islet Allograft Survival in Diabetic Mice Upon Macrophage Depletion by Clodronate-Loaded Erythrocytes
  282. A three-year longitudinal study on the effects of a diet containing genetically modified Bt176 maize on the health status and performance of sheep
  283. Inhibition of murine AIDS by pro-glutathione (GSH) molecules
  284. Cell-based drug delivery
  285. Detection and quantification of Prymnesium parvum (Haptophyceae) by real-time PCR
  286. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Lamivudine and Tenofovir
  287. Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay
  288. Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge
  289. Detection of Listeria monocytogenes using a commercial PCR kit and different DNA extraction methods
  290. Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment
  291. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
  292. Genotyping OLR1 Gene: A Genomic Biomarker for Cardiovascular Diseases
  293. Immunization with HIV protease peptides linked to syngeneic erythrocytes
  294. Long-term Treatment With Autologous Red Blood Cells Loaded With Dexamethasone 21–Phosphate in Pediatric Patients Affected by Steroid-dependent Crohn Disease
  295. Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy
  296. Current molecular techniques for the detection of microbial pathogens
  297. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir
  298. High throughput HPLC-ESI-MS method for the quantitation of dexamethasone in blood plasma
  299. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer
  300. Candidate HIV-1 Tat vaccine development: from basic science to clinical trials
  301. Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy
  302. Erythrocytes as a controlled drug delivery system: Clinical evidences
  303. Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys
  304. Monitoring of HAB species in the Mediterranean Sea through molecular methods
  305. A combination of diagnostic tools for rapid screening of ovine listeriosis
  306. Monitoring ofAlexandriumspecies in the Mediterranean Sea using a combined filter system–PCR assay detection method
  307. Immune response and protection by DNA vaccines expressing antigen 85B ofMycobacterium tuberculosis
  308. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
  309. The Use of Magnetic Nanoparticles in the Development of New Molecular Detection Systems
  310. Capture probe conjugated to paramagnetic nanoparticles for purification of Alexandrium species (Dinophyceae) DNA from environmental samples
  311. Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules
  312. Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy
  313. In Vitro Inhibition of Promyelocytic Leukemia/Retinoic Acid Receptor-α (PML/RARα) Expression and Leukemogenic Activity by DNA/LNA Chimeric Antisense Oligos
  314. Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease
  315. Development of a magnetic capture hybridization-PCR assay for Listeria monocytogenes direct detection in milk samples
  316. Perturbations of Cell Cycle Control in T Cells Contribute to the Different Outcomes of Simian Immunodeficiency Virus Infection in Rhesus Macaques and Sooty Mangabeys
  317. Development of a qualitative PCR method for the Alexandrium spp. (Dinophyceae) detection in contaminated mussels (Mytilus galloprovincialis)
  318. Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ΔV2 Env
  319. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population
  320. Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients-A Pilot Uncontrolled Study
  321. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
  322. Mechanisms of Action and Antiproliferative Properties of Brassica oleracea Juice in Human Breast Cancer Cell Lines
  323. Prognostic Role of Thymidylate Synthase Polymorphisms in Gastric Cancer Patients Treated with Surgery and Adjuvant Chemotherapy
  324. Development of new procedures for the isolation of phytoplankton DNA from fixed samples
  325. Prognostic Role of Interleukin-1β Gene and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients With Advanced Gastric Cancer
  326. Erythrocyte-based drug delivery
  327. Loss of CD127 Expression Defines an Expansion of Effector CD8+T Cells in HIV-Infected Individuals
  328. Macrophage depletion induced by clodronate-loaded erythrocytes
  329. Targeting Nucleotide Dimers Containing Antiviral Nucleosides
  330. Bovine hexokinase type I: Full-length cDNA sequence and characterisation of the recombinant enzyme
  331. Editorial
  332. Locked Nucleic Acids (LNA): Versatile Tools for Designing Oligonucleotide Decoys with High Stability and Affinity
  333. Direct detection of Listeria monocytogenes from milk by magnetic based DNA isolation and PCR
  334. Development of a Real-Time PCR Assay Using SYBR Green I for Provirus Load Quantification in a Murine Model of AIDS
  335. Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application
  336. Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients
  337. Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer
  338. Purification and characterization of a recombinant listeriolysin O expressed in Escherichia coli and possible diagnostic applications
  339. Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity
  340. Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages
  341. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs
  342. Development of a Real-Time PCR Assay for Rapid Detection and Quantification of Alexandrium minutum (a Dinoflagellate)
  343. Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid
  344. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients
  345. Predictive and Prognostic Role of E-Cadherin Protein Expression in Patients with Advanced Gastric Carcinomas Treated with Palliative Chemotherapy
  346. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility
  347. Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency
  348. Drug Delivery through Phagocytosis of Red Blood Cells
  349. Specific Changes in the Posttranslational Regulation of Nucleolin in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  350. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression
  351. Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections
  352. A new one-step RT-PCR method for virus quantitation in murine AIDS
  353. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge
  354. Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy
  355. High-level expression of the Listeria monocytogenes listeriolysin O in Escherichia coli and preliminary characterization of the purified protein
  356. Marine diatom growth on different forms of particulate silica: evidence of cell/particle interaction
  357. The G/A Nucleotide Change at cDNA Position 2494 in the E-Cadherin Gene (CDH1): Analysis in Italian Patients
  358. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model
  359. Seasonal Blooms of the HAB Dinoflagellate Alexandrium taylori Balech in a New Mediterranean Area (Vulcano, Aeolian Islands)
  360. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer
  361. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine
  362. Repeated Cycles of Alternate Administration of Fludarabine and Zidovudine Plus Didanosine Inhibits Murine AIDS and Reduces Proviral DNA Content in Lymph Nodes to Undetectable Levels
  363. HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials
  364. Inhibition of Macrophage iNOS by Selective Targeting of Antisense PNA†
  365. Design and characterization of decoy oligonucleotides containing locked nucleic acids
  366. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
  367. Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals
  368. Modulation of ICAM-1 Expression in ECV304 Cells by Macrophage-Released Cytokines
  369. The potency of acyclovir can be markedly different in different cell types
  370. Inhibition of Proteasome Activity Strongly Affects Kiwifruit Pollen Germination. Involvement of the Ubiquitin/Proteasome Pathway as a Major Regulator
  371. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus
  372. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and 9-(R)-2-(Phosphono Methoxypropyl)adenine
  373. Identification of Blood Erythroid Markers Useful in Revealing Erythropoietin Abuse in Athletes
  374. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis
  375. Antioxidant capacity of extra-virgin olive oils
  376. New drug combinations for the treatment of murine AIDS and macrophage protection
  377. Identification of the main ubiquitination site in human erythroid α-spectrin
  378. The Ubiquitin-Dependent Proteolytic System and other Potential Targets for the Modulation of Nuclear Factor-kB (NF-kB)
  379. A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus
  380. Structure of the 5′ region of the human hexokinase type I (HKI) gene and identification of an additional testis-specific HKI mRNA
  381. Ubiquitin/proteasome system
  382. Selective Inhibition of NF-kB Activation and TNF-α Production in Macrophages by Red Blood Cell-Mediated Delivery of Dexamethasone
  383. Identification of ubiquitinated repeats in human erythroid α-spectrin
  384. Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate
  385. New Treatment Protocol Including Lympholytic and Antiretroviral Drugs to Inhibit Murine AIDS
  386. Metabolism, mitochondrial uptake and toxicity of 2′,3′-dideoxycytidine
  387. Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme–membrane association control
  388. Influence of nutrient ratios on the in vitro extracellular polysaccharide production by marine diatoms from the Adriatic Sea
  389. Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients
  390. MONITORING ERYTHROPOIETIN ABUSE IN ATHLETES
  391. Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover
  392. IDENTIFICATION OF ALEXANDRIUM (DINOPHYCEAE) SPECIES USING PCR AND rDNA-TARGETED PROBES
  393. Alteration of α-spectrin ubiquitination due to age-dependent changes in the erythrocyte membrane
  394. Protein Degradation and Apoptotic Death in Lymphocytes during Fiv Infection: Activation of the Ubiquitin–Proteasome Proteolytic System
  395. Liposomes as carriers of the antiretroviral agent dideoxycytidine-5′-triphosphate
  396. Synthesis and Biological Application of a New Heterodinucleotide with Both Anti-HSV and Anti-HIV Activity
  397. cDNA Sequence of the Human Erythroid -Spectrin: Identification of a Base Deletion in the Sequence Database
  398. Efficient inhibition of macrophage TNF-α production upon targeted delivery of K48R ubiquitin
  399. Heterodimer-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiviral Drug Azidothymidine and the Antimycobacterial Drug Ethambutol
  400. Expression, Purification, and Characterization of a Recombinant Erythroid-Specific Hexokinase Isozyme
  401. Competitive PCR for Quantification of BM5d Proviral DNA in Mice with AIDS
  402. Drug delivery and targeting system
  403. Structure of the human hexokinase type I gene and nucleotide sequence of the 5′ flanking region
  404. Macrophage Protection Against Human Immunodeficiency Virus or Herpes Simplex Virus by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and Acyclovir
  405. AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Homologous Erythrocytes as a Delivery System for Preferential Immunization with Putative Protective Antigens
  406. Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide
  407. Structure and expression of the human ubiquitin fusion–degradation gene (UFD1L)
  408. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  409. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  410. Expression of hexokinase mRNA in human hippocampus
  411. Use of Nonvolatile Buffers in Liquid Chromatography/Mass Spectrometry:  Advantages of Capillary-Scale Particle Beam Interfacing
  412. Antiretroviral Effect of Combined Zidovudine and Reduced Glutathione Therapy in Murine AIDS
  413. Oxidative Protein Damage and Degradation in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  414. Ubiquitin conjugation to endogenous proteins in the dormant tuber of Helianthus tuberosus and during the first cell cycle
  415. 2′,3′-Dideoxycytidine cytotoxicity in human macrophages
  416. Targeting antiviral nucleotide analogues to macrophages
  417. Up-Regulation of the Ubiquitin-Conjugating and Proteolytic Systems in Murine Acquired Immunodeficiency Syndrome
  418. Molecular bases of hexokinase deficiency
  419. The Inhibitory Effect of ddC on Human Immunodeficiency Virus Replication Diminishes in Cells that are Chronically Exposed to the Drug
  420. Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice
  421. Structural determinants that make hexokinase susceptible to ubiquitin-and ATP- dependent proteolysis
  422. Structure of the human hexokinase type I gene
  423. Identification of α-Spectrin Domains Susceptible to Ubiquitination
  424. Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidine
  425. Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes
  426. Inhibition of Murine AIDS by Reduced Glutathione
  427. Inhibition of Murine AIDS by Combination of AZT and Dideoxycytidine 5'-Triphosphate
  428. MODULATION OF THE HEAT SHOCK UBIQUITIN POOL IN SKELETONEMA COSTATUM (BACILLARIOPHYCEAE)1
  429. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
  430. Azidothymidine Homodinucleotide-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiretroviral Drug Azidothymidine
  431. High-Level Expression and Purification of a Human “Mini”-hexokinase
  432. Assignment of the hexokinase type 3 gene (HK3) to human chromosome band 5q35.3 by somatic cell hybrids and in situ hybridization
  433. Three new mutations (P183T, V150L, 528insG) and eleven sequence polymorphisms in Italian patients with galactose-1-phosphate uridyltransferase (GALT) deficiency
  434. Lactate catabolism by enzyme‐loaded red blood cells
  435. 2′,3′-Dideoxycytidine metabolism in a new drug-resistant cell line
  436. Inhibition of HIV-1 and LP-BM5 Replication in Macrophages by Dideoxycytidine and Dideoxycytidine 5′-Triphosphate
  437. Effect of Antiviral Treatments on the Bone Marrow in Murine AIDS
  438. 2′,3′-Dideoxycytidine induced drug resistance in human cells
  439. Efficacy and Toxicity of Long-Term Administration of 2′,3′-dideoxycytidine in the LP-BM5 Murine-Induced Immunodeficiency Model
  440. UBIQUITIN INSKELETONEMA COSTATUM
  441. FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5′-triphosphate
  442. Ubiquitin Is Conjugated to the Cytoskeletal Protein α-Spectrin in Mature Erythrocytes
  443. Hexokinase Mutations that Produce Nonspherocytic Hemolytic Anemia
  444. Effect of heat stress on polyamine content and protein pattern in Skeletonema costatum
  445. Modulated red blood cell survival by membrane protein clustering
  446. Red blood cells as a delivery system for AZT
  447. Targeting dexamethasone to macrophages
  448. Preparation and characterization of biotinylated red blood cells
  449. Feline Immunodeficiency Virus Infection of Macrophages:In Vitroandin VivoInhibition by Dideoxycytidine-5′-triphosphate-Loaded Erythrocytes
  450. Red blood cell phagocytosis following hexokinase inactivation
  451. Localization and age-dependent expression of hexokinase mRNA in the rat brain
  452. The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system
  453. HPLC Analysis of Taurine in Human Plasma Sample Using the Dabs-Ci Reagent with Sensitivity at Picomole Level
  454. The female longevity phenomenon. Hypotheses on some molecular and cell biology aspects
  455. Methanol detoxification by enzyme‐loaded erythrocytes
  456. Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara district
  457. Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro
  458. Red Blood Cell Aging. Proceedings of a Symposium Held in Urbino, Italy, 24-26 September 1990.Mauro Magnani , Antonio De Flora
  459. The bone marrow in murine AIDS
  460. Direct observation of hexokinase translocation in stimulated macrophages
  461. Red blood cell age dependent modifications of inositol 1,4,5-trisphosphate
  462. Glucose-6-Phosphate Dehydrogenase Nucleotide 1311 Polymorphism in Central Italy (Marche Region)
  463. Intracellular distribution of hexokinase in rabbit brain
  464. In vitro and in vivo toxicity of 2′,3′-dideoxycytidine in mice
  465. Intracellular Distribution of Protein as a Determinant for Ubiquitination and Proteolytic Degradation
  466. Red blood cells as an antigen‐delivery system
  467. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.
  468. A recombinant human ‘mini’-hexokinase is catalytically active and regulated by hexose 6-phosphates
  469. In vitro targeting of erythrocytes to cytotoxic T‐cells by coupling of Thy‐1.2 monoclonal antibody
  470. Increased glucose metabolism by enzyme‐loaded erythrocytes in vitro and in vivo normalization of hyperglycemia in diabetic mice
  471. Acetaldehyde Oxidation by Aldehyde Dehydrogenase Loaded Erythrocytes
  472. Analysis of amino acids as DABS-derivatives with a sensitivity to the femtomole level using RP-HPLC narrow-bore columns
  473. Comparison of Uricase-Bound and Uricase-Loaded Erythrocytes as Bioreactors for Uric Acid Degradation
  474. Normalization of Hyperglycemia in Diabetic Mice by Enzyme-Loaded Erythrocytes
  475. Red Blood Cells as Advanced Drug Delivery Systems for Antiviral Nucleoside Analogues
  476. Xenobiotic Detoxification by GSH-Loaded Erythrocytes
  477. The Use of Resealed Erythrocytes as Carriers and Bioreactors
  478. Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli
  479. Human red blood cells as bioreactors for the inactivation of harmful xenobiotics
  480. Cell age dependent decay of human erythrocytes glutathione S-transferase
  481. Red Blood Cell Aging
  482. Free Radicals Promote “In Vitro” a Different Intracellular Decay of Rabbit Reticulocyte and Erythrocyte Glycolytic Enzymes
  483. Glucose-6-Phosphate Dehydrogenase Lodi^844C: A Study on Its Expression in Blood Cells and Muscle
  484. In vitro toxicity and metabolism of 2′,3′-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity
  485. Role and Mechanism of Hexokinase Decay During Reticulocyte Maturation and Cell Aging
  486. Immunological quantification of human hexokinase type I
  487. A nonlinear three-compartiment model for the administration of 2′,3′-dideoxycytidine by using red blood cells as bioreactors
  488. Preparation and characterization of monoclonal antibodies to human hexokinase type I
  489. Hexokinase: one gene or two [letter; comment]
  490. ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts
  491. Similarities and differences between human and rat hexokinases type I
  492. IN VIVO ACCELERATED ACETALDEHYDE METABOLISM USING ACETALDEHYDE DEHYDROGENASE-LOADED ERYTHROCYTES
  493. Acetaldehyde Dehydrogenase-Loaded Erythrocytes as Bioreactors for the Removal of Blood Acetaldehyde
  494. Cell age dependent decay of human erythrocytes glucose-6-phosphate isomerase
  495. Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity
  496. Improved stability of 2,3‐bisphosphoglycerate during storage of hexokinase‐overloaded erythrocytes
  497. Reversed-phase high-performance liquid chromatography separation of dimethylaminoazobenzene sulfonyl- and dimethylaminoazobenzene thiohydantoin-amino acid derivatives for amino acid analysis and microsequencing studies at the picomole level
  498. Effects of Ca2+ and lipoxygenase inhibitors on hexokinase degradation in rabbit reticulocytes
  499. Human Red Blood Cell Loading with Hexokinase-Inactivating Antibodies
  500. Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samples
  501. Improved metabolic properties of hexokinase-overloaded human erythrocytes
  502. Hexokinase type I multiplicity in human erythrocytes
  503. Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress
  504. Effect of phenylhydrazine on red blood cell metabolism
  505. Simultaneous Preparation from Human Placenta of Several Enzymes of Glucose Metabolism
  506. Superoxide anions are required for the inactivation ofEscherichia coli induced by high concentrations of hydrogen peroxide
  507. Hexokinase microheterogeneity in rabbit red blood cells and its behaviour during reticulocytes maturation
  508. Effect of age on some properties of mice erythrocytes
  509. Membrane-Bound Immunoglobulins Increase during Red Blood Cell Aging
  510. Purification, properties, and evidence for two subtypes of human placenta hexokinase type I
  511. The interaction of phosphorylated sugars with human hexokinase I
  512. Adenine and pyridine nucleotides during rabbit reticulocyte maturation and cell aging
  513. Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine
  514. Relationships between the age-dependent decay of glucose-1,6-bisphosphate synthesis, phosphoribomutase and phosphoglucomutase in human red cells
  515. Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency
  516. First trimester monitoring of a pregnancy at risk for glucose phosphate isomerase deficiency
  517. Human erythrocyte hexokinases are immunologically related
  518. Rat red blood cell hexokinase purification, properties and age-dependence
  519. Increased Erythrocyte Adenosine Deaminase Activity without Haemolytic Anaemia
  520. Redox and Energetic State of Red Blood Cells in G6PD Deficiency, Heterozygous β-Thalassemia and the Combination of Both
  521. Complete high-performance liquid chromatographic separation of 4-N,N-dimethylaminoazobenzene-4′-thiohydantoin and 4-dimethylaminoazobenzene-4′-sulphonyl chloride amino acids utilizing the same reversed-phase column at room temperature
  522. Hereditary nonspherocytic hemolytic anemia due to a new hexokinase variant with reduced stability
  523. Human erythrocyte hexokinase deficiency: a new variant with abnormal kinetic properties
  524. Hexokinase in human chorionic villi
  525. Regulatory properties of human erythrocyte hexokinase during cell ageing
  526. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells
  527. Red blood cell adenine nucleotides abnormalities in down syndrome
  528. Hexokinase in developing rabbit erythroid cells
  529. A new direct radioassay for the determination of true erythrocyte hexokinase activity
  530. Relationship between the rate of erythrocyte hexose monophosphate pathway and the glucose 6-phosphate concentration
  531. Rabbit red blood cell hexokinase:intracellular distribution during reticulocytes maturation
  532. Regulatory properties of rabbit red blood cell hexokinase at conditions close to physiological
  533. Increased Activity of Glutathione S-Transferase and Fast Decay of Reduced Glutathione in Fanconi’s Anemia Erythrocytes
  534. Rabbit red blood cell hexokinase
  535. Red Blood Cell Hexokinase in Fanconi’s Anemia
  536. Regional Mapping of Hexokinase-1 within the Short Arm of Chromosome 10
  537. Pig red blood cell hexokinase: Evidence for the presence of hexokinase types II and III, and their purification and characterization
  538. Pig red blood cell hexokinase: Regulatory characteristics and possible physiological role
  539. Prenatal prediction of duplication 10q24→qter by gene dosage of GOT1 on uncultured amniotic cells
  540. The age-dependent metabolic decline of the red blood cell
  541. Red Blood Cell Hexokinase in Tumor Bearing Mice
  542. Red blood cell glucose metabolism in trisomy 10p: possible role of hexokinase in the erythrocyte
  543. Relationship between Erythrocyte Hexokinase in Cancer Patients and Red Cell Age
  544. Red Blood Cell Galactokinase Activity and Presenile Cataracts
  545. Regional mapping of the locus for hexokinase-1 (HK1)
  546. Molecular forms of red blood cell hexokinase
  547. Solubilization, purification, and properties of rabbit brain hexokinase
  548. Adult and fetal galactokinases in human red blood cells
  549. Chromatographic fractionation of multiple forms of red blood cell hexokinase
  550. Cell survival and glutathione reductase
  551. A New Variant of Galactokinase
  552. [1] Hexokinase from rabbit red blood cells
  553. Human Erythrocyte Galactokinase: A Population Survey
  554. Expression of GALT in two unrelated 9p- patients. Evidence for assignment of the GALT locus to the 9p21 band
  555. The possibility of prenatal diagnosis by gene dosage: Confirmation of duplication 10q24→qter from Got-l activity in fetal erythrocytes
  556. Hexokinase isozymic pattern during red cell aging
  557. Action of oxidized and reduced glutathione on rabbit red blood cell hexokinase
  558. Galactokinase activity and red blood cell age
  559. Studies on the use of Sepharose-N-Aminohexanoyl-Glucosamine for purification of rabbit red blood cell hexokinase
  560. Spectrophotometric analysis of interferences due to polyols in the assay of protein by Lowry's method
  561. Comparative studies of glucose metabolism on mammals' red blood cells
  562. Decay pattern of rabbit erythrocyte hexokinase in cell aging
  563. Comparative studies of galactokinase activity on mammal's red blood cells
  564. Confirmation of regional assignment of nucleoside phosphorylase to band 14q13 by gene-dosage studies
  565. Comparative studies on red blood cell glucose phosphorylating activities of mammals
  566. Glucokinase and Hexokinase in Pig Erythrocytes
  567. Relationship between glucose phosphorylating activities and erythrocyte age
  568. Immobilization of Enzymes and Proteins on Red Blood Cells
  569. An Ex Vivo Erythrocyte Model for Investigating Oxidative Metabolism